May 10th, 2019
Scott Lassman recently was honored by Chambers USA: America’s Leading Lawyers for Business. Mr. Lassman was named a Ranked Lawyer for 2019 in the area of Pharmaceutical/Medical Products Regulatory law.
The Chambers rankings are determined by independent research into a range of qualities and evidence of an attorney's work.
Categories: Honors
Scott Lassman
Scott Lassman has more than 30 years’ experience in FDA law and policy, both as an in-house attorney and in private practice. He provides strategic advice and advocacy to small, mid-size and large pharmaceutical, biotechnology and medical device companies, as well as the trade associations that represent them and the investors who fund them. His practice covers all aspects of FDA regulatory law, with a special focus on exclusivity, biosimilars, product approval and policy matters...
For More Information